Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.

Journal:
Hepatology
Published:
DOI:
10.1097/hep.0000000000001442
Affiliations:
35
Authors:
47
Go to article
Institutions Authors Share
Stanford Medicine, United States of America (USA)
5.166667
 0.11
Drum Tower Hospital, China
5.000000
 0.11
Kaohsiung Medical University (KMU), Taiwan
3.333333
 0.07
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), KMU, Taiwan
2.666667
 0.06
First Affiliated Hospital, ZZU, China
2.000000
 0.04
The Fifth People's Hospital of Suzhou, China
2.000000
 0.04
Nippon Medical School, Japan
2.000000
 0.04
Osaka Metropolitan University (OMU), Japan
2.000000
 0.04
Hospital Italiano de Buenos Aires, Argentina
2.000000
 0.04
Kumamoto University, Japan
2.000000
 0.04
San Jose Gastroenterology (SJGI), United States of America (USA)
2.000000
 0.04
Zhenjiang Third People's Hospital, China
2.000000
 0.04
The Affiliated Hospital, Hangzhou Normal University, HZNU, China
2.000000
 0.04
Tianjin Second People's Hospital, China
1.500000
 0.03
University of Washington (UW), United States of America (USA)
1.500000
 0.03
E-Da Hospital, Taiwan
1.000000
 0.02
Nagoya City University, Japan
1.000000
 0.02
Ogaki Municipal Hospital, Japan
1.000000
 0.02
Nanjing University of Chinese Medicine (NJUCM), China
1.000000
 0.02
Saga University, Japan
1.000000
 0.02
Shinmatsudo Central General Hospital, Japan
1.000000
 0.02
St. Marianna University School of Medicine, Japan
1.000000
 0.02
National Sun Yat-Sen University (NSYSU), Taiwan
1.000000
 0.02
Nanjing University (NJU), China
1.000000
 0.02
Tianjin Medical University (TMU), China
0.500000
 0.01
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA)
0.333333
 0.01
Interested in Medical Biochemistry and Metabolomics?